RecruitingPostpartum Depression (PPD)
Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression
Eligible age
18+ yrs
Accepts
Women
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.
Sponsor: University of Michigan
You may qualify if…
- ✓ 1. ≤ 6 months postpartum
- ✓ 2. EPDS score \>10
You may not qualify if…
- ✕ 1. Current or past-year substance use disorder
- ✕ 2. Lifetime history of bipolar disorder or psychotic disorder
- ✕ 3. Active suicidal intent
- ✕ 4. Retinal pathology or history of eye surgery
- ✕ 5. Current use of photosensitizing medications
- ✕ 6. Untreated sleep-disordered breathing, untreated restless legs syndrome, or narcolepsy
- ✕ 7. Psychotherapy or psychotropic medications started/dose changed in past month (psychotherapy started and/or current medication at stable dose ≥ 4 weeks are permitted)
- ✕ 8. Medical conditions contraindicated for mBLT (e.g., epilepsy/seizures)
Where it's recruiting
Michigan
Ann Arbor
Source: ClinicalTrials.gov · NCT07766161 · last updated 2026-08-14